PharmGKB summary
- 1 October 2013
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Pharmacogenetics and Genomics
- Vol. 23 (10), 563-585
- https://doi.org/10.1097/fpc.0b013e328364db84
Abstract
No abstract availableKeywords
This publication has 142 references indexed in Scilit:
- NF-κB, the first quarter-century: remarkable progress and outstanding questionsGenes & Development, 2012
- The Ca2+-dependent Phosphatase Calcineurin Controls the Formation of the Carma1-Bcl10-Malt1 Complex during T Cell Receptor-induced NF-κB ActivationOnline Journal of Public Health Informatics, 2011
- NFAT pulls the strings during CD4+ T helper cell effector functionsBlood, 2010
- Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugsThe Pharmacogenomics Journal, 2010
- Donor Age and Renal P-Glycoprotein Expression Associate with Chronic Histological Damage in Renal AllograftsJournal of the American Society of Nephrology, 2009
- CYP3A7, CYP3A5, CYP3A4, and ABCB1 Genetic Polymorphisms, Cyclosporine Concentration, and Dose Requirement in Transplant RecipientsTherapeutic Drug Monitoring, 2008
- Transforming growth factor-β in T-cell biologyNature Reviews Immunology, 2002
- Clinically Significant Drug Interactions with CyclosporinClinical Pharmacokinetics, 1996
- Clinical Pharmacokinetics of TacrolimusClinical Pharmacokinetics, 1995
- Cyclosporin Clinical PharmacokineticsClinical Pharmacokinetics, 1993